Skip to main content
HR 3794 118th Congress House Health Advanced technology and technological innovations Congressional oversight Emergency planning and evacuation Health technology, devices, supplies Infectious and parasitic diseases Public contracts and procurement Research administration and funding Research and development Technology transfer and commercialization

FLASH Act of 2023

Introduced: June 5, 2023 Introduced by: Garcia, Robert Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 22, 2023
Sponsor introductory remarks on measure. (CR H3077)
Jun 9, 2023
Referred to the Subcommittee on Health.
Jun 5, 2023
Referred to the House Committee on Energy and Commerce.
Jun 5, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Fast-track Logistics for Acquiring Supplies in a Hurry Act of 2023 or the FLASH Act of 2023

This bill expands federal contracting and other authorities to support the development and acquisition of products and supplies that are necessary for national public health and health security.

Specifically, the Department of Health and Human Services (HHS) may use noncompetitive procedures to procure medical countermeasures (e.g., vaccines), chemical materials and reagents, manufacturing supplies, and similar items that are needed to develop products for national public health and health security.

Additionally, HHS may acquire, subject to dollar limits and other conditions, innovative commercial products and services by soliciting proposals and selecting proposals through peer review.

Further, the bill expands the activities of the Biomedical Advanced Research and Development Authority (BARDA) to include supporting the design and development of prototypes for products to diagnose, mitigate, prevent, treat, or otherwise respond to biological, chemical, radiological, or nuclear threats, including pandemics or epidemics. If BARDA enters an initial transaction to design or develop such a test or prototype using competitive procedures, BARDA may use noncompetitive procedures for a follow-on transaction to produce the test or prototype.

What's happening now June 22, 2023

Sponsor introductory remarks on measure. (CR H3077)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3794: FLASH Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-3794/
MLA
"H.R. 3794: FLASH Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-3794/.
Bluebook (legal)
H.R. 3794, 118th Cong. (2026), https://openamerica.io/bill/118-HR-3794/.
Markdown link
[H.R. 3794: FLASH Act of 2023](https://openamerica.io/bill/118-HR-3794/)
Report a problem